Conditions: Insulin Resistance; Type 2 Diabetes; Obesity & Overweight; Healthy Adult Participants
Interventions: Drug: Alpelisib 300 mg; Diagnostic Test: Alpelisib Challenge Test (ACT): Mixed Meal Tolerance Test (MMTT) after taking alpelisib; Diagnostic Test: Hyperglycemic clamp
Sponsors: Columbia University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Pisa
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
